MARKET ACCESS 101

MARKET ACCESS 101

The Westin Toronto Airport Hotel
950 Dixon Road, Toronto, ON, M9W 5N4

The Westin Toronto Airport Hotel is pleased to offer you a
special group rate of $229.00 per night. 
Take advantage and make your reservations by May 5, 2025.

CAHR's industry-renowned Market Access 101 Conference will be held in-person on June 3rd. This course is designed to educate market access professionals and other industry professionals on the fundamentals of Canadian pharmaceutical access and reimbursement. Participants will gain insights into Canadian reimbursement systems and Payers’ perspectives to develop a broader understanding of the multiple factors required to successfully navigate through market access and reimbursement pathways.

CAHR is pleased to present the return of this industry classic – a primer on everything you need to know about Market Access in Canada, taught by experts in each subject, and the foundation of the Certified Market Access Professional credential. Our accomplished faculty will dive deeply into all aspects of our complex environment – from evidence consideration to strategy to reimbursement and everything in between. This conference will empower and reward delegates with information, insights and interpretations that will enhance their careers in Market Access, while providing networking opportunities.

AGENDA
The agenda is updated periodically or as needed.

8:30am Breakfast

9:00am
Welcome & Housekeeping 
Emcee Rebecca Vieira, Vertex Pharmaceuticals Incorporated

9:15am
Overview of Market Access and Canadian Landscape
Arvind Mani, Morse Consulting

Market Access in Canada is a broad field encompassing many different areas. Join Arvind Mani as he introduces the field (e.g., what market access entails in the Canadian market) and provides an overview of what market access professionals need to know in light of the changing public policy landscape affecting the profession.

10:00am
Evidence – Clinical & Real World
Lindy Forte, Eversana

This session will focus on the data expectations of payers and HTA bodies, as they evaluate/consider the value of new drug products for drug plan listing. In addition, we will review the evolving role of real-world evidence (RWE) in reimbursement.

10:45am Networking Break

11:15am
PMPRB
Anna Apostolakis, IQVIA

New PMPRB Regulations will soon be implemented. The price tests and guidelines that will be used to operationalize the Regulations are in flux. This presentation will discuss what we know and what we need to watch for in terms of the review of new patented drugs.

11:45am Networking Lunch

12:30pm
Introduction to the Private Payer Market
Cheryl Bielicz, Incyte

Join Cheryl as she walks through a brief overview of private drug coverage in Canada: from where drugs fit overall into employer sponsored benefits, to a discussion on the different types of management strategies insurers use to control drug costs.

1:00pm
PSP Overview
Alison Oliver,  Cencora Innomar Strategies

This session will cover the basics of a Patient Support Program (PSP), including why PSPs are needed in Canada, what are the key elements of a PSP, what is a typical PSP journey as well as drug lifecycle considerations, high level vendor landscape, preparing for an RFP and metrics to measure success when designing a PSP.

1:30pm
Preparing a HTA Submission Dossier for Public Payers
Patrick Mott, Eversana

This session will serve as an introduction to drug reimbursement processes including planning and the components of the submission dossier. Due to time constraints, the focus of this session will be on CDA-AMC.

2:15pm  Networking Break

2:45pm
HEOR
Jean-Éric Tarride, McMaster University

This session will provide an overview of key HEOR concepts to support HTA submissions including the types of economic evaluations, model-based economic evaluations and budget impact analyses.

3:30pm
The pan-Canadian Pharmaceutical Alliance (pCPA)
Katherine Scott, Morse Consulting

This session will provide an overview of the pCPA (e.g., history, processes, outcomes, and outlook for the future) before simulating a mock negotiation.

4:30pm Wrap UP Session & Closing remarks
Emcee Rebecca Vieira, Vertex Pharmaceuticals Incorporated

REGISTRATION FEES
Fees include educational sessions, breakfast, lunch and coffee breaks.
MEMBER: $795 + $103.35 (13% HST) = $898.35
NON-MEMBER: $1195 + $155.35 (13% HST) = $1,350.35
*PATIENT / STUDENT ATTENDEE: $150.00 + $19.50 (13% HST) = $169.50
* Registration code required.

Limited number of special discounts available to patient groups and students. Please contact the CAHR office to obtain a code.

CAHR reserves the right to cancel or change speakers, content and date
without prior notice. We assume no liability for these changes.

CANCELLATION POLICY: For cancellations two (2) weeks or more in advance, delegates will receive a 75% refund. For cancellations made less than two (2) weeks in advance, no refunds are given. Delegate substitutions will be accepted at no cost.